Diane Marie Del Valle

13PUBLICATIONS
218CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyInnate immunityMolecular targetsPeripheral nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Apr 19, 2026
Gemcitabine plus Nivolumab with Carboplatin or Oxaliplatin in Cisplatin-Ineligible Patients with Metastatic Urothelial Carcinoma: A Randomized Phase II Trial.

|Mar 03, 2026
TCR sequencing in cancer immunology and immunotherapy: what, when, where, why, and how.

Yohei Nose, Igor Figueiredo, Kevin Tuballes

|Jan 27, 2026
Humoral IgG1 responses to tumor antigens underpin clinical outcomes in immune checkpoint blockade.

Edgar Gonzalez-Kozlova, Robert Sweeney, Igor Figueiredo

|Feb 26, 2025
Immunological biomarkers of response and resistance to treatment with cabozantinib and nivolumab in recurrent endometrial cancer.

Vladimir Roudko, Diane Marie Del Valle, Emir Radkevich

|Feb 03, 2025
Peripheral Transcriptomics in Acute and Long-Term Kidney Dysfunction in SARS-CoV-2 Infection.

Pushkala Jayaraman, Madhumitha Rajagopal, Ishan Paranjpe

|Dec 12, 2024
Baseline colitogenicity and acute perturbations of gut microbiota in immunotherapy-related colitis.

Joan Shang, Diane Marie Del Valle, Graham J Britton

Pageof 3